Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Esomeprazole Mg vs Nexium in Healthy Subjects (Fed)
NCT02680132Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- May 2011
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of esomeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started May 2011; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02680132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680132.